Cimzia
- Product NDC
- 50474-750
- 11-digit product format
- 504740750
- Labeler code
- 50474
- Product ID
- 50474-750_4b984e6f-72ac-4fdc-e063-6394a90af105
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- certolizumab pegol
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- UCB, Inc.
- Application
- BLA125160
- Marketing category
- BLA
- Marketing start
- 2025-03-01
- Substance
- CERTOLIZUMAB PEGOL
- Active strength
- 200 mg/mL
- Pharmacologic classes
- Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| UMD07X179E | CERTOLIZUMAB PEGOL | 428863-50-7 | CERTOLIZUMAB PEGOL |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 50474-750-10 | 50474075010 | 1 SYRINGE, GLASS in 1 CARTON (50474-750-10) / 1 mL in 1 SYRINGE, GLASS | 2025-03-01 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Cimzia | UCB, Inc. | UCB Pharma S.A. | Vetter Pharma Fertigung GmbH & Co. KG | Unither Manufacturing, LLC | UCB Farchim S.A. | 2026-02-24 | HUMAN PRESCRIPTION DRUG LABEL | 47 |
| Cimzia | UCB, Inc. | UCB Pharma S.A. | Vetter Pharma Fertigung GmbH & Co. KG | Unither Manufacturing, LLC | UCB Farchim S.A. | 2025-07-08 | HUMAN PRESCRIPTION DRUG LABEL | 43 |